TickerFacts.

Biolife Solutions Inc (BLFS): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$7.57M
Year ended 2025-12-31
-4.4%
3-year compound annual growth
$11.82M2010-12-31: $318.9K2011-12-31: $516.5K2012-12-31: $463.6K2013-12-31: $487.8K2014-12-31: $871.1K2015-12-31: $1.38M2016-12-31: $2.03M2017-12-31: $1.19M2018-12-31: $1.30M2019-12-31: $3.17M2020-12-31: $6.72M2021-12-31: $11.82M2022-12-31: $8.67M2023-12-31: $5.51M2024-12-31: $4.75M2025-12-31: $7.57M$7.57M
2010-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$7.57M+59.3%2026-02-26, From 2025-01-01
2024-12-31$4.75M-13.9%2026-02-26, From 2024-01-01
2023-12-31$5.51M-36.4%2026-02-26, From 2023-01-01
2022-12-31$8.67Mn/c2025-03-03, From 2022-01-01
2021-12-31$11.82M+75.9%2024-02-29, From 2021-01-01
2020-12-31$6.72M+112.1%2023-03-31, From 2020-01-01
2019-12-31$3.17M+144.1%2022-03-31, From 2019-01-01
2018-12-31$1.30M+8.8%2020-05-15, From 2018-01-01
2017-12-31$1.19M-41.2%2019-03-15, From 2017-01-01
2016-12-31$2.03M+47.1%2018-03-09, From 2016-01-01
2015-12-31$1.38M+58.3%2017-03-15, From 2015-01-01
2014-12-31$871.1K+78.6%2016-02-25, From 2014-01-01
2013-12-31$487.8K+5.2%2015-03-12, From 2013-01-01
2012-12-31$463.6K-10.2%2014-02-12, From 2012-01-01
2011-12-31$516.5K+62.0%2013-03-29, From 2011-01-01
2010-12-31$318.9Kn/a2012-03-29, From 2010-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Biolife Solutions Inc (BLFS)2025-12-31$7.57M+59.3%
Vaso Corp (VASO)2025-12-31$728.0K-14.5%
Ceribell, Inc. (CBLL)2025-12-31$19.14M+41.2%
Outset Medical, Inc. (OM)2025-12-31$21.23M-44.7%
Electromed, Inc. (ELMD)2026-06-30$1.31M+31.9%
Iridex Corp (IRIX)2026-01-03$3.67M-32.7%
Axogen, Inc. (AXGN)2025-12-31$32.88M+18.4%
Stereotaxis, Inc. (STXS)2025-12-31$9.38M-3.9%
electroCore, Inc. (ECOR)2024-12-31$2.36M-55.6%

Compare BLFS, VASO, CBLL, OM side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗